February 1, 2023 Certara to Report Fourth Quarter and Full Year 2022 Financial Results on March 1st, 2023
January 4, 2023 Certara Acquires Vyasa, an Artificial Intelligence Company that Delivers Predictions to Accelerate Scientific Innovation
December 8, 2022 Certara Announces the Completion of Arsenal Capital Partners’ Investment and the Appointment of David Spaight to the Board of Directors
November 7, 2022 Arsenal Capital Partners Increases Investment in Global Biosimulation Leader Certara with $449M Stock Purchase
October 19, 2022 Japan’s Pharmaceuticals and Medical Devices Agency (PMDA) Renews Licenses of Certara’s Software for Evaluating Regulatory Submissions